GIACOBELLO SCOTT M. (Chief Financial Officer) sold 42.5% of their position (218.60K shares) of WHITEHAWK THERAPEUTICS, INC. on the open market
Open‑market sale worth $882.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/17/2026ACC: 0001754154-26-000010
Officer· Chief Financial Officer
Since Nov 2021
-218.60K
Net shares
Net seller
$882.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
218.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−77K
Price / share
$3.86
Trade value
$297.22K
% of position
15.0%
4/15/2026
513.82K→436.82K
Common Stock
Direct
Shares
−141.60K
Price / share
$4.13
Trade value
$584.81K
% of position
32.4%
4/16/2026
436.82K→295.22K
Total
Net shares
−218.60K
Net value
-$882.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | S · Sale | −77K | $3.86 | $297.22K | 15.0% | 513.82K | 436.82K |
| Common Stock Direct | 4/16/2026 | S · Sale | −141.60K | $4.13 | $584.81K | 32.4% | 436.82K | 295.22K |
| Total | −218.60K | -$882.03K | ||||||
Derivative Transactions0
No derivative transactions reported